The company have significantly advanced its development of an innovative treatment for ATTR-CM, utilizing the investigational drug. Preliminary patient data suggests potential improvements for individuals affected from https://bridgebio285907.blogrelation.com/48785315/firm-advances-attr-cm-treatment-through-the-drug